NOT-FD-24-001: Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science

Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional

Notice Number:

NOT-FD-24-001

Key Dates

Release Date:

January 22, 2024

Related Announcements

December 28, 2023 - Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional. See NOFO RFA-FD-24-029.

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

The purpose of this Notice is to update the email address for Scientific/Research Contact Patricia Koussis from [email protected] to [email protected].

Currently reads:

Scientific/Research Contact(s)

Patricia Koussis
CDER
Email: [email protected]

Modified to read:

Scientific/Research Contact(s)

Patricia Koussis
CDER
Email: [email protected]

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Terrin Brown
Office of Acquisitions & Grants Services (OAGS)
Food and Drug Administration
Email: [email protected]